<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02685215</url>
  </required_header>
  <id_info>
    <org_study_id>1912677</org_study_id>
    <nct_id>NCT02685215</nct_id>
  </id_info>
  <brief_title>Prognostic Factors , Morbidity and Mortality in Patients With Muscular Dystrophies Admitted in ICU</brief_title>
  <official_title>Prognostic Factors, Morbidity, Mortality and Long Term Survival in Patients With Muscular Dystrophies Admitted in Intensive Care Unit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre d'Investigation Clinique et Technologique 805</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre d'Investigation Clinique et Technologique 805</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Muscular dystrophies are neuromuscular disorders with disability. Restrictive pulmonary
      failure and cardiomyopathy affect prognosis.The investigators aim to establish predictive
      factors for mortality and morbidity in Intensive care unit (ICU ) and to describe the long
      term follow up after ICU discharge.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Muscular dystrophies are neuromuscular disorders with disability. Restrictive pulmonary
      failure and cardiomyopathy affect prognosis. Little is known about morbidity and mortality of
      patients with muscular dystrophies admitted in intensive care unit (ICU).The investigators
      aim to describe the spectrum of patients with muscular dystrophies admitted in ICU , to
      establish predictive factors for ICU mortality and morbidity and to describe the long term
      follow up after ICU discharge.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">January 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>ICU mortality rate</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>rate of patients needing tracheostomy in ICU</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rate of patients with cardiogenic shock</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rate of patients with septic shock</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospital mortality rate</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">280</enrollment>
  <condition>Muscular Dystrophies</condition>
  <condition>Intensive Care (ICU) Myopathy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All patients with muscular dystrophies admitted in ICU since 2005
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  admitted in ICU

          -  Duchenne muscular dystrophy

          -  Becker muscular dystrophy

          -  LGMD

          -  Steinert disease

          -  Pompe disease

          -  FSH

          -  metabolic disease

          -  mitochondrial disease

          -  others genetic muscular disease

        Exclusion Criteria:

          -  brain injury

          -  minor patient
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>abdallah Fayssoil, MDPhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Raymond Poincare Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hopital Raymond Poincare</name>
      <address>
        <city>Garches</city>
        <zip>92380</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 14, 2016</study_first_submitted>
  <study_first_submitted_qc>February 17, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 18, 2016</study_first_posted>
  <last_update_submitted>August 22, 2017</last_update_submitted>
  <last_update_submitted_qc>August 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre d'Investigation Clinique et Technologique 805</investigator_affiliation>
    <investigator_full_name>Abdallah FAYSSOIL</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <keyword>intensive care unit</keyword>
  <keyword>muscular dystrophy</keyword>
  <keyword>mortality</keyword>
  <keyword>prognosis</keyword>
  <keyword>tracheostomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscular Dystrophies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

